Besides, PGAM1 has no obvious correlation with the clinical pathological characteristics of patients (Table 1) including age; lymph node (LN) metastasis; tumor‐necrosis‐metastasis (TNM) stage; and estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) statuses. This evidence concerns the gene ERBB2 and neoplasm.